Interaction of toll-like receptors and ACE-2 with different variants of SARS-CoV-2: A computational analysis.

Bioimpacts

Department of Catalysis and Chemical Reaction Engineering, ‎National Institute of Chemistry, Hajdrihova 19, SI-1001 Ljubljana, Slovenia.

Published: January 2024

Introduction: Computational studies were performed to investigate the unknown status of endosomal and cell surface receptors in SARS-CoV-2 infection. The interactions between Toll-like receptors (TLRs)- 4/7/8/9 or ACE2 receptor and different SARS-CoV-2 variants were investigated.

Methods: The RNA motifs for TLR7, TLR8 and a CpG motif for TLR9 were analyzed in different variants. Molecular docking and molecular dynamics (MD) simulations were performed to investigate receptor-ligand interactions.

Results: The number of motifs recognized by TLR7/8/9 in the Alpha, Delta and Iranian variants was lower than in the wild type (WT). Docking analysis revealed that the Alpha, Delta and some Iranian spike variants had a higher affinity for ACE2 and TLR4 than the WT, which may account for their higher transmission rate. The MD simulation also showed differences in stability and structure size between the variants and the WT, indicating potential variations in viral load.

Conclusion: It appears that Alpha and some Iranian isolates are the variants of concern due to their higher transmissibility and rapid spread. The Delta mutant is also a variant of concern, not only because of its closer interaction with ACE2, but also with TLR4. Our results emphasize the importance of ACE2 and TLR4, rather than endosomal TLRs, in mediating the effects of different viral mutations and suggest their potential therapeutic applications.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11298020PMC
http://dx.doi.org/10.34172/bi.2024.30150DOI Listing

Publication Analysis

Top Keywords

ace2 tlr4
12
toll-like receptors
8
performed investigate
8
alpha delta
8
delta iranian
8
variants
7
interaction toll-like
4
receptors ace-2
4
ace-2 variants
4
variants sars-cov-2
4

Similar Publications

Article Synopsis
  • COVID-19 vaccines successfully reduce both symptomatic infections and severe outcomes, but unequal distribution has led to vaccine-resistant strains, especially in lower-income countries.
  • The study introduces a new approach using dissolved microneedle array patches (MAP) with the S1 monomer and RS09, which enhances immune response and provides a longer-lasting immunity compared to traditional vaccination methods.
  • MAP vaccines show impressive stability and efficacy even after long-term storage, with minimal degradation at high temperatures, suggesting they could be a viable alternative to existing cold-chain-dependent vaccines.
View Article and Find Full Text PDF

In vitro study on efficacy of SKF7, a Malaysian medicinal plant product against SARS-CoV-2.

BMC Complement Med Ther

September 2024

Herbal Medicine Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.

Background: In early 2020, COVID-19 pandemic has mobilized researchers in finding new remedies including repurposing of medicinal plant products focusing on direct-acting antiviral and host-directed therapies. In this study, we performed an in vitro investigation on the standardized Marantodes pumilum extract (SKF7) focusing on anti-SARS-CoV-2 and anti-inflammatory activities.

Methods: Anti-SARS-CoV-2 potential of the SKF7 was evaluated in SARS-CoV-2-infected Vero E6 cells and SARS-CoV-2-infected A549 cells by cytopathic effect-based assay and RT-qPCR, respectively.

View Article and Find Full Text PDF

Background: The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial to viral entry and can cause cardiac injuries. Toll-like receptor 4 (TLR4) and NOD-, LPR-, and pyrin-domain-containing 3 (NLRP3) inflammasome are critical immune system components implicated in cardiac fibrosis. The spike protein activates NLRP3 inflammasome through TLR4 or angiotensin-converting enzyme 2 (ACE2) receptors, damaging various organs.

View Article and Find Full Text PDF

Interaction of toll-like receptors and ACE-2 with different variants of SARS-CoV-2: A computational analysis.

Bioimpacts

January 2024

Department of Catalysis and Chemical Reaction Engineering, ‎National Institute of Chemistry, Hajdrihova 19, SI-1001 Ljubljana, Slovenia.

Introduction: Computational studies were performed to investigate the unknown status of endosomal and cell surface receptors in SARS-CoV-2 infection. The interactions between Toll-like receptors (TLRs)- 4/7/8/9 or ACE2 receptor and different SARS-CoV-2 variants were investigated.

Methods: The RNA motifs for TLR7, TLR8 and a CpG motif for TLR9 were analyzed in different variants.

View Article and Find Full Text PDF

The late 2019 emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, caused profound and unprecedented disruption to the global socio-economic structure, negatively affecting millions of lives worldwide. A typical hallmark of severe COVID-19 is hyper inflammation due to aberrant cytokine release (cytokine storm) by innate immune cells. Recent studies have revealed that SARS-CoV-2, through its spike (S) protein, can activate the body's innate immune cells via Toll-Like Receptors (TLRs), particularly TLR4.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!